Indian stocks: Visit www.stage2stocks.com →

Tactile Systems Technology, Inc.

Stage 4 · Declining · week 7

As of Oct 22, 2026, Tactile Systems Technology is in Stage 4, the downtrend phase, now in week 7 (since Sep 8, 2026). It closed at $23.54, 28.8% below its 52-week high and below its 200-day average, which is falling.

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. More about the company

$23.54
+1.12% today
$533M · Small cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is TCMD early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S1 19w
S2 17w
S4 17w
S2 23w
S3 14w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 1w → S3 7w → S4 11w → S1 19w → S3 5w → S4 12w → S1 9w → S2 17w → S3 6w → S4 17w → S1 9w → S2 23w → S3 14w → S2 10w → S3 1w → S4 6w current
Total tracked: 165 weeks across 16 stage runs.

TCMD among Medical Devices11th of 141 by relative strength

All 141 →
Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#StockStageRS1M
1TXGStage 2 · wk 4899−7.8%
2RCELStage 2 · wk 1398+40.8%
3BFLYStage 2 · wk 2698−26.0%
4HAEStage 2 · wk 1796+8.7%
5GKOSStage 2 · wk 2596+15.1%
6AXGNStage 3 · wk 295−15.3%
7NEOGStage 2 · wk 1495−11.7%
8BVSStage 2 · wk 1595+10.5%
…11TCMDStage 4 · wk 789+4.9%
vs 52W High
-28.8%
$14.92 lo$33.05 hi
28.8% below 52W high, ongoing decline
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 7
1w13w26w
Week 7, early Stage 4 decline
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-9.7%
200 DMA: $26.07 · sloping down
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
0.47x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
↗
Short-term trend rising gently
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+4.9%
3M
-14.3%
6M
-3.7%
YTD
-14.1%
1Y
+59.5%
Scan Membership
Breakout Watch
Latest: 2024-10-29
7 appearances in last 60 days. First seen: 2018-10-16.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S4
Wk 7 · Vol 0.47x
2026-10-21S4
Wk 7 · Vol 0.40x
2026-10-20S4
Wk 7 · Vol 0.67x
2026-10-19S4
Wk 6 · Vol 0.52x
2026-10-16S4
Wk 6 · Vol 0.67x
2026-10-15S4
Wk 6 · Vol 0.66x
2026-10-14S4
Wk 6 · Vol 0.50x
2026-10-13S4
Wk 6 · Vol 0.49x
2026-10-12S4
Wk 5 · Vol 0.56x
2026-10-09S4
Wk 5 · Vol 0.43x
2026-10-08S4
Wk 5 · Vol 1.16x
2026-10-07S4
Wk 5 · Vol 0.67x
Moving averages & range
50 DMA
$22.77
200 DMA
$26.07
52W High
$33.05
52W Low
$14.92
5D Low
$22.52
Resistance levels (recent highs)
20d High
$23.54
60d High
$30.14
120d High
$31.87
250d High
$33.05
Next resistance
+28.0%
to 60d High
P/E (TTM)
21.8
Forward 16.2
Earnings Growth (YoY)
+144.1%
Revenue +8.6%
ROE
+11.9%
Profit margin +7.1%
Dividend Yield
0.00%
P/B 2.4

Tactile Systems Technology: quick answers

What stage is Tactile Systems Technology in?

As of Oct 22, 2026, Tactile Systems Technology (TCMD) is in Stage 4, the downtrend phase. It entered Stage 4 on Sep 8, 2026 and is in week 7. What the four stages mean

Is Tactile Systems Technology in an uptrend?

No. Tactile Systems Technology is in a Stage 4 downtrend. It trades 9.7% below its 200-day average, which is falling.

How far is Tactile Systems Technology from its 52-week high?

Tactile Systems Technology closed at $23.54 on Oct 22, 2026, 28.8% below its 52-week high of $33.05. Its 52-week low is $14.92.

How has Tactile Systems Technology performed over the past year?

As of Oct 22, 2026, Tactile Systems Technology is up 59.5% over the past year and down 14.1% so far in 2026.

Which sector and industry is Tactile Systems Technology in?

Tactile Systems Technology is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.